Q32 Bio (QTTB) Accounts Payables (2017 - 2026)
Q32 Bio (QTTB) posted quarterly Accounts Payables of $653000.0 for Q1 2026, down 75.92% year-over-year from $2.7 million in Q1 2025, and down 25.71% quarter-over-quarter from $879000.0 in Q4 2025.
Q32 Bio (QTTB) Accounts Payables (2017 - 2026) Analysis & Trends
Q32 Bio's Accounts Payables history runs 10 years deep, the most recent figure standing at $653000.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 75.92% year-over-year to $653000.0; the TTM figure through Mar 2026 stood at $653000.0 (down 75.92% YoY), while the FY2025 annual figure was $879000.0, down 70.59% from the prior year.
- Accounts Payables for Q1 2026 stood at $653000.0, down from $879000.0 in the prior quarter.
- The five-year high for Accounts Payables was $9.9 million in Q1 2022, with the low at $653000.0 in Q1 2026.
- The 5-year median for Accounts Payables is $3.0 million (2024), against an average of $3.3 million.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables jumped 203.15% in 2023, then plunged 83.88% in 2024.
- Q32 Bio's Accounts Payables stood at $1.1 million in 2022, then surged by 203.15% to $3.5 million in 2023, then decreased by 13.81% to $3.0 million in 2024, then plunged by 70.59% to $879000.0 in 2025, then slipped by 25.71% to $653000.0 in 2026.
- Business Quant data shows QTTB's Accounts Payables at $653000.0 in Q1 2026, $879000.0 in Q4 2025, and $973000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 653,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | 973,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 4.96 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 7.80 Mn |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 3.64 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 4.84 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Mar 31, 2022 | 9.89 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 3.52 Mn |